However, these current biomarkers, such as epidermal growth factor receptor (EGFR) and Kirsten rat sarcoma virus (KRAS) oncogene homologs, do not fully represent the complex mechanisms of lung cancer progression [35, 36]. The gene discussed is KRAS; the disease is lung cancer.